Cabergoline Tablets

Product Description

Since Last many years Saintroy Lifescience is leading manufacture, export and supplier of Cabergoline Tablets from Surat, Gujarat, India.Cabergoline Tablets used as an adjunct to SSRI antidepressants as there is some evidence that it counteracts certain side effects of those drugs.

Tags: Cabergoline Tablets   manufacturer, Cabergoline Tablets   exporter,  Cabergoline Tablets    supplier, and     Cabergoline Tablets   , whogmp approved    Cabergoline Tablets    manufacturer and supplier,    Cabergoline Tablets   distributor,   Cabergoline Tablets   dropshipper,    Cabergoline Tablets 1 mg,  CabergolineTablets 1 mg supplier,    Cabergoline Tablets  1 mg.

ISO/GMP/cGMP/WHOGMP/NAFDACapproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.

Registration: Saintroy Lifescience is interested in registration of own brand or customer brands in ministry of health of clients country and we also provide the products samples,COA, COPP, ACTD or CTDDossier, DMF, Manufacturing license, Free sales certificate and other required documents.

Export Country :Saintroy Lifescience    Cabergoline Tablets export to USA, Canada, Germany, Europe,France, Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon,Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand,Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, Ivory Costa, Oman, Guatemala,Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia,Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan,Uzbekistan, Kazakhstan.

Key Benefits of Cabergoline Tablets

Cabergoline Tablets provide effective management of hyperprolactinemia by lowering elevated prolactin levels, which helps restore hormonal balance and fertility in affected individuals. As a dopamine agonist, these tablets are also used as adjunct therapy in Parkinson's disease to improve motor symptoms. With a high purity of 99% and pharmaceutical-grade formulation, patients benefit from reliable treatment outcomes and safety.


Usage and Dosage Guidance

These tablets must only be used according to a qualified healthcare provider's prescription. The commonly recommended strength is 0.5 mg per tablet. Patients should follow their physician's dosage instructions and never exceed the prescribed amount. Taking cabergoline with food may reduce gastrointestinal side effects. Adherence to proper usage enhances therapeutic outcomes and minimizes adverse reactions.


Safe Handling and Storage

To maintain the effectiveness and longevity of cabergoline tablets, store them below 25C, protected from moisture and light. Avoid leaving the strips in humid environments such as bathrooms. Always keep the medication in its original packaging until use and out of reach of children. Discard any tablets beyond their two-year shelf life or showing signs of degradation.